Patent · US Active

Therapeutic multi-peptides T specific immune therapy for treatment of brain metastasis

US10434157B2 · kind B2 · utility

3Cited by
0References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 6, 2014
Grant dateOct 8, 2019
Priority date
Expiry dateApr 12, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/70
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a peptide vaccine composition OSE-2101 for treatment of brain metastasis in HLA-A2 positive patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.